Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

Invigor Medical vs VyrarX

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #5Desk pick
Invigor Medical

A long-running pharmacy operator with steady mid-market pricing and a broad wellness catalog.

vs
Dispatch #177
VyrarX

VyrarX is a LegitScript-certified telehealth platform offering compounded semaglutide (from $179/month) and compounded tirzepatide (from $329/month) via weekly injection, prescribed by licensed US physicians.

Invigor Medical takes this head-to-head with the higher Desk Score, 90/100 (A−) against 67/100 (C) for VyrarX. VyrarX still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Invigor Medical

90/100

A−

Overall

VyrarX

67/100

C

Price transparency

85
78

State access

78
24

Molecule range

88
66

Onboarding speed

90
82

Support responsiveness

88
88

Licensing & trust

92
79

The spec sheet

FieldInvigor MedicalVyrarX
Semaglutide$199/mo$179/mo (starting dose, compounded)
Tirzepatide$339/mo$329/mo (starting dose, compounded)
CoverageNot disclosedCoverage not published
Brand-nameCompounded onlyCompounded only
Oral optionInjectable onlyInjectable only
Best forPatients who want GLP-1 care within a wider, established health program.Readers who want compounded semaglutide ($179/mo) and tirzepatide ($329/mo) via LegitScript-certified telehealth in 47 states.
Desk Score90/100A−67/100C

The verdict

Desk pick — Invigor Medical

Invigor Medical takes this head-to-head with the higher Desk Score, 90/100 (A−) against 67/100 (C) for VyrarX. VyrarX still holds its ground where its strengths line up with yours.

Choose Invigor Medical if…

Patients who want GLP-1 care within a wider, established health program.

$199/mo sema · $339/mo tirz · Not disclosed

Choose VyrarX if…

Readers who want compounded semaglutide ($179/mo) and tirzepatide ($329/mo) via LegitScript-certified telehealth in 47 states.

$179/mo (starting dose, compounded) sema · $329/mo (starting dose, compounded) tirz · Coverage not published

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Invigor Medical · VyrarX.

Also on the board

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.

More head-to-heads

Or see the full comparison hub and the complete board.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.